Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
12.89
-0.04 (-0.31%)
At close: Jun 25, 2026, 4:00 PM EDT
12.55
-0.34 (-2.64%)
After-hours: Jun 25, 2026, 4:46 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $658.57 million as of June 25, 2026. Its market cap has increased by 187.06% in one year.
Market Cap
658.57M
Enterprise Value
519.89M
1-Year Change
187.06%
Ranking
Category
Stock Price
$12.89
Market Cap Chart
Since March 16, 1993, Tenax Therapeutics's market cap has increased from $110.17M to $658.57M, an increase of 497.76%. That is a compound annual growth rate of 5.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 658.57M | 33.17% |
| Dec 31, 2025 | 494.55M | 126.39% |
| Dec 31, 2024 | 218.45M | 3,233.86% |
| Dec 29, 2023 | 6.55M | 31.60% |
| Dec 30, 2022 | 4.98M | -81.01% |
| Dec 31, 2021 | 26.21M | 11.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 707.53M |
| Oculis Holding AG | 705.94M |
| Immix Biopharma | 694.10M |
| Climb Bio | 692.85M |
| CorMedix | 687.24M |
| Rigel Pharmaceuticals | 684.95M |
| Aclaris Therapeutics | 673.18M |
| Candel Therapeutics | 667.49M |